Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (214K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Wu, Y.
Right arrow Articles by Hofstra, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Y.
Right arrow Articles by Hofstra, R. M.
Related Collections
Right arrow Polymorphism/mutation detection
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE
Nucleic Acids Research Article e9


Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE
Introduction
Materials And Methods
   DNA amplification
   Denaturing gradient gel electrophoresis (DGGE)
   Constant denaturant gel electrophoresis (CDGE)
   Combined denaturing gel electrophoresis
Results And Discussion
Acknowledgements
References


Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE

Ying Wu, Rein P. Stulp, Peter Elfferich, Jan Osinga, Charles H. C. M. Buys, Robert M. W. Hofstra*

Department of Medical Genetics, University of Groningen, Antonius Deusinglaan 4, 9713 AW Groningen, The Netherlands

Received March 12, 1999; Revised and Accepted June 4, 1999

ABSTRACT

Denaturing gradient gel electrophoresis (DGGE) has proven to be a powerful pre-screening method for the detection of DNA variants. If such variants occur, however, in DNA fragments that are very rich in G and C, they may escape detection. To overcome this limitation, we tested a novel gel system which combines DGGE and constant denaturant gel electrophoresis (CDGE), as it might have the advantages of both methods. Indeed, this combination had the advantages of both methods, good separation of heteroduplex molecules and prevention of total strand dissociation, and it proved successful in the detection of DNA variants in several GC-rich fragments.

INTRODUCTION

Denaturing gradient gel electrophoresis (DGGE) of GC-clamped DNA fragments (1-5) is a powerful tool to detect small mutations in PCR-amplified DNA fragments. When correctly designed and applied the mutation detection rate is virtually 100% (4-6). Application of DGGE to GC-rich fragments, however, has proved very difficult. Variants are hard to detect, presumably because of the small temperature difference between the melting temperature (Tm) of the GC-rich DNA fragment and that of the clamp. Therefore, the part of the denaturing gradient in which the mutation will become visible is very small and, because of the high melting temperature, will be at the very bottom of the gel in which the fragment melts completely, implying the risk that the fragment will run off the gel. This makes reliable mutation detection of GC-rich fragments extremely difficult. In some cases, complete strand dissociation can be prevented by adjusting the length of the GC clamp, thus reducing the mobility of the partially melted migrating fragment (7). For extremely GC-rich sequences (Tm > 80°C), however, a longer clamp is still not sufficient to prevent total strand dissociation. Several solutions have been suggested to this problem. One might be the use of primers with a chemical clamp instead of a GC clamp. The chemical clamp should prevent complete strand dissociation of the fragments, which is the main problem in mutation detection by DGGE in GC-rich fragments. Such primers have a photoactivatable intercalating agent (psoralen) at their 5[prime]-end which stabilises the PCR fragment by covalently binding the two strands (8,9). We tested the use of such a chemical clamp, however, several mutations remained undetectable in GC-rich fragments. Another alternative might be to use constant denaturant gel electrophoresis (CDGE) instead of DGGE. In CDGE, a single denaturing condition is used, which is between the Tm of the fragment and that of the GC clamp (10-12). CDGE, however, is not the method of choice for searching for unknown mutations in relatively large DNA fragments with multiple melting domains, since each variant/domain requires a specific electrophoretic condition for optimal resolution (13). Furthermore, heteroduplex molecules, which melt at a lower temperature than homoduplexes, may not be detected, since all fragments may melt immediately in the relatively high concentration of denaturant. If heteroduplex molecules are not detected, the mutation detection rate decreases dramatically. Another alternative has been reported by Guldberg and colleagues (14), who treated template DNA with sodium bisulphite to lower the Tm of GC-rich DNA fragments. The disadvantage of this method is that for the modified strand extra primers must be designed. Also, methylation of DNA may give false positive results.

To facilitate detection of mutations in GC-rich DNA fragments, we compared DGGE with CDGE and tested the use of a combination of DGGE and CDGE and compared this with the use of the individual methods. The combined DGGE/CDGE system was chosen as it might have the advantages of both systems; heteroduplex molecules may become visible in the DGGE component, while the CDGE component should prevent complete strand dissociation.

MATERIALS AND METHODS

DNA amplification

PCR amplification of RET exons 1 and 4 and a part of MSH6 exon 1 was carried out as previously described (15,16). A 60 bp GC clamp was attached to one of the primers. The primer sequences are available on request.

Denaturing gradient gel electrophoresis (DGGE)

An aliquot of 20 µl of the amplified product was transferred to a 0.75 mm thick 9% polyacrylamide (PAA) gel (acrylamide:bisacrylamide 37.5:1) containing a 50-85% denaturing gradient of urea-formamide [100% urea-formamide (UF) contains 7 M urea and 40% deionized formamide]. DGGE was performed in 0.5× TAE (1× TAE = 40 mM Tris-acetate pH 8.0, 20 mM Na-acetate, 1 mM Na2EDTA) at 60°C for 1500 V/h using a 19 cm gel. The separation pattern was visualised by ethidium bromide (EtBr) staining for 10 min and UV transillumination of the gel.

Constant denaturant gel electrophoresis (CDGE)

An aliquot of 20 µl of the amplified product was transferred to a 9% PAA gel containing 78% UF. CDGE was performed in 0.5× TAE at 60°C for 1500 V/h using a 19 cm gel. The gel was stained with EtBr.

Combined denaturing gel electrophoresis

An aliquot of 20 µl of the amplified product was transferred to a 9% PAA gel containing a combined denaturing gradient. For RET exon 4 and the part of MSH6 exon 1, the gel consisted of a CDGE part (78% UF) in the lower 10 cm of the gel and a DGGE part (30-78% UF) in the upper 9 cm of the gel. Electrophoresis was performed in 0.5× TAE at 60°C for 1500 V/h. For RET exon 1, the gel consisted of a CDGE part (83% UF) in the lower 10 cm of the gel and a DGGE part (30-83% UF) in the upper 9 cm of the gel. Electrophoresis was performed in 0.5× TAE at 58°C for 1500 V/h. The gel was stained with EtBr.

RESULTS AND DISCUSSION

To test whether the detection of mutations by DGGE and CDGE can be improved by a combined DGGE/CDGE gel system, we used exon 4 of the RET gene, which has a very high GC content (71%), giving a Tm value of 84°C, and in which a mutation (Glu235Lys) was previously found because of an abnormal DGGE pattern (Fig. 1A, lane 3).


Figure 1. Mutation analysis of GC-rich fragments of the RET and MSH6 genes. (A) DGGE and (B) CDGE analysis of RET exon 4 and its flanking intronic sequence from two control individuals (lanes 1 and 3) and from a Hirschsprung patient who was a mutation carrier (Glu235Lys) (lane 2). The mutation could not be convincingly demonstrated in either gel. (C) Combined denaturing gel electrophoresis of RET exon 4 on the same sample set (lanes 1-3) and on DNA samples from some additional Hirschsprung patients (lanes 4-6). The mutated PCR products (lanes 2 and 5) give the expected four bands. (D) DGGE analysis of RET exon 1 and its flanking intronic sequence in three individuals. All bands are fuzzy and diffuse in the DGGE gel. (E) Combined denaturing gel electrophoresis of RET exon 1 from the same three individuals shows sharp and focused bands. (F) DGGE analysis of a part of MSH6 exon 1 in three individuals. All bands are fuzzy and a neutral variant could not be demonstrated with regular DGGE (lanes 2 and 3). (G) Combined denaturing gel electrophoresis on the same samples. A clear difference between the homoduplex bands of the variant PCR products (lanes 2 and 3) and that of the normal product (lane 1) can be seen.

Figure 1A shows the DGGE analysis of RET exon 4 from two controls (lanes 1 and 3) and from the mutation carrier (lane 2). A 60 bp GC clamp was used, since attachment of a 40 bp GC clamp to the fragment did not lead to a focused band(s) in the gel. Even when the fragments were melted, they kept on running through the gel (data not shown). With longer electrophoresis times bands run off the gel. Although the DGGE patterns of the normal (lanes 1 and 3) and mutated (lane 2) PCR products show some differences, the mutation could not be convincingly demonstrated.

Figure 1B shows the CDGE analysis of RET exon 4 on the same test panel. As mentioned, detection of heteroduplex molecules by CDGE may be a problem. There is a difference between the mutated PCR product (lane 2) and the control products (lanes 1 and 3), but again the mutation could not be convincingly demonstrated.

Figure 1C shows the results of the combined DGGE and CDGE gel system for RET exon 4. The combined gel system improved detection of the mutation remarkably. Using the same DNA samples as used for DGGE and CDGE, one focused band in the lanes containing the normal PCR fragments can be seen (lanes 1 and 3), whereas the mutated PCR products (lane 2) give the expected four bands (two heteroduplexes and two homoduplexes). When we screened a large number of Hirschsprung patients, another variant in RET exon 4 was readily detected (Fig. 1C, lane 5).

To further demonstrate the use of this combined gel system, we applied it to RET exon 1 (77% GC, Tm 85°C) and to part of MSH6 exon 1 (74% GC, Tm 84°C). Figure 1D and E shows a comparison of DGGE analysis with the combined gel system in RET exon 1. The combined gel system remarkably improved the band resolution of this fragment, showing much sharper bands in the combined gel (Fig. 1E) than in the corresponding DGGE gel (Fig. 1D). No variant has yet been detected in this fragment. Figure 1F and G shows the same comparison of analysis of the part of MSH6 exon 1. Screening this fragment with the combined DGGE/CDGE gel system we found a neutral variant. Lane 2 shows a heterozygous individual, whereas lane 3 shows a homozygous individual. Although in both DGGE and combined DGGE/CDGE fuzzy bands are observed, the resolution of the combined gel system proved to be much better. A clear difference between the homoduplex bands of the variation (lanes 2 and 3) and that of the normal product (lane 1) can be seen (Fig. 1G). No heteroduplex bands were detected.

Based on these results and on additional analysis of several other GC-rich fragments, such as GDNF exon 1 and BRCA2 exon 1 (data not shown), we conclude that a combined DGGE and CDGE gel system is an effective prescreening method for mutations in GC-rich DNA fragments. Which constant denaturant concentration should be used can be determined either from the theoretical melting curve or preferably from a perpendicular DGGE experiment.

ACKNOWLEDGEMENTS

We are grateful to our colleagues in the laboratory for advice and discussions. This work was supported by the Dutch Cancer Society (Y.W., grant 97-1544).

REFERENCES

1. Fischer, S.G. and Lerman,L.S. (1983) Proc. Natl Acad. Sci. USA, 80, 1579-1583. MEDLINE Abstract

2. Myers, R.M., Maniatis,T. and Lerman,L.S. (1987) Methods Enzymol., 155, 501-527 MEDLINE Abstract

3. Sheffield, V.C., Cox,D.R., Lerman,L.S. and Myers,R.M. (1989) Proc. Natl Acad. Sci. USA, 86, 232-236. MEDLINE Abstract

4. Abrams, E.S., Murdaugh,S.E. and Lerman,L.S. (1990) Genomics, 7, 463-475. MEDLINE Abstract

5. Guldberg, P., Henriksen,K.F. and Guttler,F. (1993) Genomics, 17, 141-146.

6. Guldberg, P., Nedergaard,T., Nielsen,H.J., Olsen,A.C., Ahrenkiel,V. and Zeuthen,J. (1997) Hum. Mutat., 9, 348-355. MEDLINE Abstract

7. Wu, Y., Hayes,V.M., Osinga,J., Mulder,I.M., Looman,M.W.G., Buys,C.H.C.M. and Hofstra,R.M.W. (1998) Nucleic Acids Res., 26, 5432-5440. MEDLINE Abstract

8. Scott, B.R., Pathak,M.A. and Mohn,G.R. (1976) Mutat. Res., 39, 29-74. MEDLINE Abstract

9. Fernandez, E., Bienvenu,T., Desclaux-Arramond,F., Beldjord,K., Kaplan,J.C. and Beldjord,O.C. (1993) PCR Methods Appl., 3, 122-124. MEDLINE Abstract

10. Børresen, A.L., Hovig,E., Smith-Sørensen,B., Malkin,D., Lystad,S. Andersen,T.I., Nesland,J.M., Isselbacher,K.J. and Friend,S.H. (1991) Proc. Natl Acad. Sci. USA, 88, 8405-8409. MEDLINE Abstract

11. Hovig, E., Smith-Sørensen,B., Brogger,A. and Børresen,A.L. (1991) Mutat. Res., 262, 63-71. MEDLINE Abstract

12. Smith-Sørensen, B., Hovig,E., Andersson,B. and Børresen,A.L. (1992) Mutat. Res., 269, 41-53. MEDLINE Abstract

13. Ridanpää, M., Burvall,K., Zhang,L.H., Husgafvel-Pursiainen,K. and Önfelt,A. (1995) Mutat. Res., 334, 357-364. MEDLINE Abstract

14. Guldberg, P., Grønbæk,K., Aggerholm,A., Platz,A., Straten,P., Ahrenkiel,V., Hokland,P. and Zeuthen,J. (1998) Nucleic Acids Res., 26, 1548-1549. MEDLINE Abstract

15. Hofstra, R.M.W., Sijmons,R.H., Stelwagen,T., Stulp,R.P., Kousseff,B.G., Lips,C.J.M., Steijlen,P.M., Van Voorst Vader,P.C. and Buys,C.H.C.M. (1996) J. Invest. Dermatol., 107, 215-218. MEDLINE Abstract

16. Wu, Y., Nyström-Lahti,M., Osinga,J., Looman,M.W.G., Peltomäki,P., Aaltonen,L.A., de la Chapelle,A., Hofstra,R.M.W. and Buys,C.H.C.M. (1997) Genes Chromosomes Cancer, 18, 269-278. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +31 50 363 2925; Fax: +31 50 363 2947; Email: r.m.w.hofstra{at}med.rug.nl


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: jnl.info{at}oup.co.uk
Last modification:
Copyright© Oxford University Press, 1999.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Print PDF (214K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Wu, Y.
Right arrow Articles by Hofstra, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Y.
Right arrow Articles by Hofstra, R. M.
Related Collections
Right arrow Polymorphism/mutation detection
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?